Four-Year Outcome of Aflibercept Treatment-Naïve Patients for Neovascular Age-Related Macular Degeneration: Evidence from a Clinical Setting

Table 2

Qualitative OCT results over visits. SRF (sub retinal fluid), IRF (intraretinal fluid), HRD (hyper-reflective dots), SHE (subretinal hyper exudation), and EZ (ellipsoid zone) disruption.

	Inclusion n = 48	3 months n = 45	6 months n = 44	12 months n = 41	24 months n = 35	36 months n = 31	48 months n = 31
SRF	29 (57%)	3 (7%)	8 (18%)	5 (12%)	6 (17%)	5 (16%)	6 (19%)
IRF	25 (53%)	7 (16%)	9 (20%)	8 (20%)	10 (29%)	9 (29%)	12 (39%)
NO FLUID	3 (6%)	38 (84%)	21 (48%)	25 (61%)	23 (66%)	21 (68%)	18 (58%)
HRD	43 (91%)	36 (80%)	28 (64%)	26 (63%)	15 (43%)	22 (71%)	23 (74%)
SHE	27 (57%)	16 (36%)	14 (32%)	8 (20%)	7 (20%)	11 (35%)	10 (32%)
EZ DISRUPTION	44 (94%)	35 (78%)	30 (68%)	34 (83%)	31 (89%)	27 (87%)	29 (94%)